Alves, LuísaCardoso, SandraSilva, DinaMendes, TiagoMaroco, J. P.Nogueira, JoanaLima, MarisaPereira, Miguel TábuasBaldeiras, InêsSantana, IsabelDe Mendonça, AlexandreGuerreiro, Manuela2020-07-092020-07-092020-06-26Journal of Neuropsychology Doi: 10.1111/jnp.1221817486653http://hdl.handle.net/10400.12/7688Patients diagnosed with amnestic mild cognitive impairment (aMCI) are at high risk of progressing to dementia. It became possible, through the use of biomarkers, to diagnose those patients with aMCI who have Alzheimer's disease. However, it is presently unfeasible that all patients undergo biomarker testing. Since neuropsychological testing is required to make a formal diagnosis of aMCI, it would be interesting if it could be used to predict the amyloid status of patients with aMCI.engjournal article10.1111/jnp.12218